The new private label offering provides a concept-to-market partnership for both new and established brands looking to develop new hemp-derived products for the growing CBD market.
Socati Corp. (Austin, TX) is launching a private label division for its fully-customizable portfolio of hemp-derived cannabinoid ingredients. The new private label offering provides a concept-to-market partnership for both new and established brands looking to develop new hemp-derived products for the growing CBD market.
“With the creation of Socati’s private label division, we’re able to provide an efficient route to market for those looking to introduce new hemp-infused products or improve existing product manufacturing processes.” said Socati CEO, Josh Epstein, in a press release. “It means brands and product innovators can respond quickly to changing consumer tastes and market trends, developing and launching high specification, quality products at speed and scale without tying up their existing manufacturing capacity or setting up their own costly infrastructure.”
The customizable private label products Socati offers now include crystalized flavored powder, gummies, tinctures, softgels, pressed tablets, and two-piece capsules. Socati’s Montana-based processing facility complies with Global Food Safety Initiative (GFSI)-recognized benchmarking requirements and adheres to Good Manufacturing Practice (GMP) standards for manufacturing.